Brands: Neupogen · Releuko · Filgrastim
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amgen, Inc | unknown | 10 | SUPPLYING |
| Amneal Pharmaceuticals LLC | generic | 6 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. — Recalling firm: Amgen, Inc. — Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy…
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months. — Recalling firm: Amgen, Inc. — Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia, France/French Guiana, Germany, Ireland, Italy…
